Evidence map›Paper›PMID 31686029›Full record

ArticleNature microbiology2020

Asymmetric distribution of TLR3 leads to a polarized immune response in human intestinal epithelial cells.

Megan L Stanifer, Markus Mukenhirn, Stephanie Muenchau, Kalliopi Pervolaraki, Takashi Kanaya, Dorothee Albrecht, Charlotte Odendall, Thomas Hielscher, Volker Haucke, Jonathan C Kagan and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 62 citations in OpenAlex.

  1. Animal organoids as models for integrated One Health research.One health (Amsterdam, Netherlands) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Listen to Your Gut: Key Concepts for Bioengineering Advanced Models of the Intestine.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. iScience · 2023
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

Megan L StaniferSchaller Research Group at CellNetworks, Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany. m.stanifer@dkfz.de.ORCID http://orcid.org/0000-0002-5606-1297
Markus MukenhirnSchaller Research Group at CellNetworks, Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany.
Stephanie MuenchauSchaller Research Group at CellNetworks, Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany.
Kalliopi PervolarakiSchaller Research Group at CellNetworks, Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany.
Takashi KanayaLaboratory for Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Dorothee AlbrechtSchaller Research Group at CellNetworks, Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany.
Charlotte OdendallDepartment of Infectious Diseases, King's College London, London, UK.
Thomas HielscherDivision of Biostatistics, DKFZ, Heidelberg, Germany.
Volker HauckeDepartment of Molecular Pharmacology and Cell Biology, Leibniz-Forschungsinstitut für Molekulare Pharmakologie and Faculty of Biology, Chemistry and Pharmacy, Freie Universität Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0003-3119-6993
Jonathan C KaganHarvard Medical School and Division of Gastroenterology, Boston Children's Hospital, Boston, MA, USA.
Sina BartfeldResearch Centre for Infectious Diseases, Institute for Molecular Infection Biology, Julius-Maximilians-University of Wuerzburg, Wuerzburg, Germany.ORCID http://orcid.org/0000-0003-2493-8282
Hiroshi OhnoLaboratory for Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.ORCID http://orcid.org/0000-0001-8776-9661
Steeve BoulantSchaller Research Group at CellNetworks, Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany. s.boulant@dkfz.de.ORCID http://orcid.org/0000-0001-8614-4993
Heidelberg University · DERIKEN Center for Integrative Medical Sciences · JPBoston Children's Hospital · USKing's College London · GBLeibniz-Forschungsinstitut für Molekulare Pharmakologie · DE

Funding

Wellcome Trust 206200/Z/17/Z
6 · The paper itself

Abstract

Intestinal epithelial cells (IECs) act as a physical barrier separating the commensal-containing intestinal tract from the sterile interior. These cells have found a complex balance allowing them to be prepared for pathogen attacks while still tolerating the presence of bacterial or viral stimuli present in the lumen of the gut. Using primary human IECs, we probed the mechanisms that allow for such a tolerance. We discovered that viral infections emanating from the basolateral side of IECs elicit a stronger intrinsic immune response in comparison to lumenal apical infections. We determined that this asymmetric immune response is driven by the clathrin-sorting adaptor AP-1B, which mediates the polarized sorting of Toll-like receptor 3 (TLR3) towards the basolateral side of IECs. Mice and human IECs lacking AP-1B showed an exacerbated immune response following apical stimulation. Together, these results suggest a model where the cellular polarity program plays an integral role in the ability of IECs to partially tolerate apical commensals while remaining fully responsive to invasive basolateral pathogens.

Indexed as

Adaptor Protein Complex 1AnimalsCell PolarityCells, CulturedGene Knockdown TechniquesHumansInterferonsInterleukin-6Intestinal MucosaMiceToll-Like Receptor 3VirusesAdaptor Protein Complex 1InterferonsInterleukin-6Toll-Like Receptor 3

Identifiers

PMID31686029
OpenAlexW2982812488

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.